Gritstone bio, Inc. Class Action Lawsuit - GRTS

The filed complaint alleges that Gritstone bio, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company would be unable to launch the Phase 2b CORAL Study, it's approved COVID-19 vaccine, in the timeframe it had represented to investors; (ii) the foregoing would impair Gritstone’s ability to obtain external funding in connection with the Study, thereby negatively affecting Gritstone’s ability to maintain its balance sheet and cash position; (iii) accordingly, Gritstone overstated its ability to successfully develop and commercialize its products; (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

In order to be eligible to join the GRTS class action lawsuit, you must have incurred a loss on shares of Gritstone purchased during the class period listed above.

If you suffered a loss in Gritstone during the relevant time frame or pursuant to the relevant offering(s), you have until August 6, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.